Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

NCT03619252 is registered in ClinicalTrials.gov with Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology as lead sponsor.

NCT NCT03619252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03619252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Lead sponsor
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2018
Completion date
June 30, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia, multiple myeloma, pneumococcal infection, pneumococcal pneumonia